预测临床试验结果:五项实证研究及其影响的综合
Perspectives in biology and medicine
|April 25, 2024
概括
医疗专家经常难以准确预测临床试验结果. 汇总专家预测可以揭示试验成功的信号,改善医学研究和决策.
科学领域:
- 医学研究 医学研究
- 临床试验方法论 临床试验方法论
- 决策分析 决策分析
背景情况:
- 专家的期望显著影响医学研究决策.
- 准确预测临床试验结果对于有效的医疗保健政策和研究至关重要.
- 评估专家预测能力提供了对判断质量的洞察力.
研究的目的:
- 审查评估医学专家预测临床试验结果能力的研究.
- 探索专家预测对改善决策的有用性.
- 针对专家试验预测的批评和总结发现.
主要方法:
- 关于专家预测临床试验结果的五项经验研究的综述.
- 分析影响预测准确性和实用性的因素.
- 对综合专家预测与个人预测的检查.
主要成果:
- 临床试验经常产生令人惊的结果,挑战专家预测.
- 个人专家对试验结果和招聘的预测往往没有信息.
- 综合的专家预测包含了关于试验成功的可辨别信号,特别是对于积极的结果.
结论:
- 专家预测,特别是聚合时,为潜在的试验成功提供了有价值的见解.
- 需要进一步的研究来完善专家预测方法和应用.
- 提出了初步的政策建议,以利用医学研究和医疗保健中的专家判断.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Introduction to Epidemiology
722
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
722
Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


